CAS Number: 8015-60-9
Aerial summits and seeds are used. It contains a great deal of flavonoids, steroids, cumestans, vitamins and minerals Attributed effects but not clinically tested are: agonist of estrogen, antianemic and diuretic. Also, there is not reliable data that would support its use as galactagogue. At latest update, relevant published data on excretion into breast milk were not found. Because its estrogenic effect it should not be consumed during pregnancy and breastfeeding. Caravanina which is one of the components, is toxic if continuously used. Pancytopenia, Hemolytic anemia and Lupus Erythematosus have been described as induced by frequent consumption of germinated-seeds or tablets of alfalfa. Cautious measures before consumption of herbal infusions should include: 1. Make sure that the source is reliable: occurrance of intoxication cases after mistakenly use of a toxic plant, poisoning by consumption of heavy metal containing substances or contaminated food by bacterial or fungal toxins. 2. Avoid excessive use. The “natural products” are not harmless at whatever dosage: the plants contain active substances that have been the source of our common pharmaceutical drugs. They may be a cause of poisoning if consumed in high quantity or for a long time.
Seaweed. The stem of the plant is used.It contains large amounts of mucilage and minerals, including iodine which appears in variable amounts that can be significant, in such a way that it may be a cause a hyperthyroidism-like disease (anxiety, insomnia, tachycardia, palpitations).It may also contain heavy metals, being a species of seaweed with a high ability of contamination by toxic products. The commission E of the German Health Ministry has not approved any clinical indication, discouraging its use. At latest update no published data on excretion into breast milk were found. However, there is information from other algae whose consumption is known to increase iodine levels in the plasma and breast milk.There have been reports of hypothyroidism in infants whose mothers have included in their diet important quantities of seaweed. There is no evidence of effectiveness on increasing milk production. The most effective method to increase milk production should be done by strengthening maternal self-confidence, evaluate and correct problems along with an effective support to breastfeeding mothers.
CAS Number: 90046-12-1
Seaweeds contain large amounts of mucilage and minerals, including iodine which appears in variable amounts that can be significant, in such a way that it may be a cause a hyperthyroidism-like disease (anxiety, insomnia, tachycardia, palpitations).It may also contain heavy metals, being a species of seaweed with a high ability of contamination by toxic products. Seaweed consumption increases levels of iodine in plasma and breast milk.There have been reports of hypothyroidism in infants whose mothers have included in their diet important quantities of seaweed. There is no evidence of effectiveness on increasing milk production. The most effective method to increase milk production should be done by strengthening maternal self-confidence, evaluate and correct problems along with an effective support to breastfeeding mothers. It is recommended to obtain information on the composition of any particular algae and avoid it or use it in very moderate amount in case of iodine content would be important.
We are working on a comment for this product.
CAS Number: 84696-05-9
Roots and leaves are used. It contains allantoin, tannins, and pyrrolizidine alkaloids. Unproved effect: topical anti-inflammatory. Indications after Commission E of German Ministry of Health: contusion with undamaged skin. Do not apply on the breast. Pyrrolizidine alkaloids are highly hepatotoxic and poses an increased risk of liver carcinoma and cirrhosis to both the mother and the infant. Consider not to use it at all.
CAS Number: 977000-27-3
Se utilizan las flores y también raíces y hojas de esta planta herbácea.Contiene lactonas sesquiterpénicas, aceite esencial, flavonoides y trazas de alcaloides pirrolizidínicos.Uso tópico sobre piel íntegra.Indicaciones en medicina tradicional sin pruebas de su eficacia: antiinflamatorio tópico en contusiones, esguinces y dolores musculares localizados (EMA 2014). No aplicar sobre piel dañada.Es muy tóxica por vía oral (Anderson 2017) habiéndose descrito gastroenteritis, arritmia cardiaca problemas neurológicos y muerte (WHO 2007 p.77, n.a.l. 2001) en personas que la tomaron y un caso de anemia hemolitica grave en un recién nacido de 9 días cuya madre tomaba infusión de arnica (Miller 2009). A fecha de última actualización no encontramos datos publicados sobre su excreción en leche materna. La pequeña dosis y la escasa absorción plasmática de la mayoría de preparaciones dermatológicas tópicas hacen poco probable el paso de cantidad significativa a leche materna. No aplicar sobre el pecho para que el lactante no lo ingiera, ni en áreas extensas o por periodos prolongados para evitar absorción sistémica. Conviene lavarse las manos después de la aplicación de arnica para evitar un posible contacto con la boca del lactante.
CAS Number: 303-98-0
We are working on a comment for this product.
CAS Number: 7761-88-8
Avoid using it on the breast or cleanse thoroughly before nursing.
Used in the treatment of promyelocitic leukemia in adults.
CAS Number: 7440-57-5
One case of facial edema that was barely related to this drug has been described. It has an extremely long half-life span.
Bismuth salts are used alone or together with other components in preparations against gastritis and diarrhea.Bismuth salicylate contains about 60% bismuth and 40% salicylate. At latest update no published data on excretion into breast milk were found. Bismuth is not absorbed into the systemic circulation of the mother. There may be a risk of absorption of salicylate in the case of bismuth salicylate, although in small quantity (<1% of the maternal dose), but no cases of Reye's syndrome have been reported after taking bismuth salicylate or other non-acetylated salicylate compounds. Due to the otherwise minimum risk of Reye's syndrome and the indiscriminate use of bismuth subsalicylate for treatment of gastroenteritis cannot be justifiable since most of gastroenteritis do not require medication instead a simply adequate hydration, a safer alternative should be desirable while breastfeeding, like the other salts of bismuth (citrate, etc).
CAS Number: 7726-95-6
It is naturally found as a bromide, and, industrially used on processing fuels, natural gas, photography fluids, and as a tranquilizer (not longer recommended). Bromide liberates a red steam that is irritant and may enter the breast milk. Eczema and somnolence have been described. Mothers who would be labor exposed (photographic film development) should receive enough ventilation. Monitoring of blood level may be considered. Benefits of breastfeeding are largely more important than risk related to the presence of mild level environment pollutants in human milk, in many instances, they are at lower content than those found in cow’s milk or other foods. (Codex alimentarius FAO-WHO).
CAS Number: 7440-43-9
Environmental pollutant. Heavy metal produced by zinc and charcoal mining industry, water plumbing, tobacco smoking, and burning of residual material. Benefits of breastfeeding are largely more important than risk related to the presence of mild level environment pollutants in human milk, in many instances, they are at lower content than those found in cow’s milk or other food. (Codex alimentarius FAO-WHO).
CAS Number: 7440-47-3
Heavy metal that in its trivalent oxidative states (3+) has a great nutritional value since it acts as a trace element (trace element) that enhances the action of insulin and is involved in the metabolism of carbohydrates, fats and proteins. Meat, seafood, brewer's yeast, whole grains and nuts (especially walnuts), among others, are very rich in chromium. The recommended intake in nursing mothers is 45 micrograms daily (Ares Segura 2015). The average concentration of chromium in breast milk is 1 nanogram / mL, ranging between 0.2 and 7 ng / mL and is independent of plasma levels and maternal daily intake (Kumpulainen 1980, Anderson 1993, Mohamedshah 1998). With a varied and balanced diet not mineral supplements are needed. Excessive intake of chromium can cause skin problems in infants (Adachi 2007). No increased concentrations of chromium in milk or problems in breastfed by mothers with hip containing chromium in its composition (Nelis 2013, Oppermann 2015) Not to be confused with states hexavalent (6+) industrial and irritating, toxic and carcinogenic effects (see tab chromic acid or chromium trioxide).
CAS Number: 7440-48-4
Gray powder or metal, odorless. There is a risk of asthma crisis if cobalt powder is inhaled. It can be a cause of skin, ocular and respiratory tract irritation. Acetate, sulfate, trioxide and nitrate cobalt salts are potentially carcinogenic. Mandatory measures to prevent inhalation (room air extraction and respiratory protection) and ingestion (avoid eating, drinking or smoking in the work place). The industry must ensure a Threshold Limit Value (TLV) (TWA as well) less than 0.05 mg/m3 (cobalt salts less than 0.002 mg/m3). Biological Exposition Index (BEI) on the last labor week day: 15 micrograms/L in the urine, 1 microgram/L in the blood. Benefits of breastfeeding are largely more important than risk related to the presence of mild level environment pollutants in human milk, in many instances, they are at lower content than those found in cow’s milk or other foods. (Codex alimentarius FAO-WHO).
Several ferrous salts of iron (ascorbate, aspartate, citrate, chloride, fumarate, gluconate, lactate, oxalate, succinate, sulfate, glycine sulfate, etc.) are used in oral administration for treating or preventing iron deficiency anemia.Its molecular weight varies from 170 for the fumarate and succinate, and from 280 for lactate and sulfate to 400 for aspartate and ascorbate. Characteristics of iron metabolism in the body make unlikely that it would be excreted in a significant amount into breast milk.It is a medication used for treatment of Neonatal Anemia in premature babies. Iron is excreted in small amounts in human milk, usually being enough for covering the daily needs of infants due to its high bioavailability. There is no correlation between mother's daily intake of iron and its concentration in breast milk.Iron supplementation to the mother does not increase levels of iron in breast milk or infant plasma significantly. Excessive supplementation can reduce the zinc concentration in milk. WHO List of Essential Medicines 2002: compatible with breastfeeding.
The various contrast media that are gadolinium derivatives and used for explorations with Magnetic Resonance Imaging (MRI) are considered compatible with breastfeeding because they are quickly eliminated (elimination half-life of less than 2 hours). They undergo very little metabolic changes and are virtually non-absorbable orally. They are structurally very similar to each other. Some have been shown to have no or minimal excretion into the milk. Less than 0.04% of the dose given to the mother ends just going into the milk.Due to its low oral bioavailability, intestinal absorption should be less than 1% of the dose took by the infant.The maximum dose received by the infant is considered less than 0.0004% of the maternal dose, which is much less than the dose administered to a newborn infant who undergoes a MRI scan. Most Radiology Scientific Societies agree that after an MRI scan is not necessary to temporarily stop breastfeeding. Some authors recommend avoiding the use on lactating women of some Gadolinium contrast media that would pose a high risk for developing Systemic Nephrogenic Fibrosis, especially in the neonatal period, like gadoversetamide, and gadodiamide dimeglumine, by using instead low-risk ones like gadoterate, gadoteridol and gadobutrol. See below the information of this related group:
CAS Number: 15750-15-9
Pump-out breast milk and keep it in refrigerator for some days before procedure. After test is done, keep-on pumping the breast (to stimulate milk production), and, dispose it for 8 to 24 hours (1 week if dose is 20 Mbq=0,5mCi). Feed the baby with stored milk.(Choose the shortest half-life span radionucleotide as possible)
CAS Number: 554-13-2
It is excreted into breast milk in amounts that may be clinically significant and can be as high as a half of that reached in mother’s plasma and up to one third of the therapeutic level in the infant. In infants and newborns (5 days), premature babies and dehydrated or infected infants, who may show reduced clearance mechanisms for lithium, there have been reports of clear signs of lithium toxicity caused by ingestion of breast milk: cyanosis, lethargy, hypotonia or slight increase in TSH. However, there are numerous cases of infants whose mothers were on lithium who did not show any clinical, growth or neurodevelopmental problem at the short or long term. Breastfeeding is less risky for healthy term infants whose mothers are treated with lithium when she or her family has capacity enough to monitor the occurrence of adverse effects, medical supervision and, whenever necessary, monitoring of lithium levels in the mother-infant dyad. Mothers should stop taking lithium 1 to 2 days before delivery or cesarean section in order to decrease plasma levels in the newborn. Lithium may be, or not, a cause of increased Prolactin and galactorrhea.
CAS Number: 7439-97-6
Environmental pollutant that is used for manufacturation of batteries, fungicidal products, dental amalgam, and contaminated fish. Most of mercury present in breast milk does it as an inorganic substance which is almost non-absorbable. Breastfeeding should be discontinued whenever a mother is contaminated or intoxicated. It may be a source of neurological troubles. Benefits of breastfeeding are largely more important than risk related to the presence of mild level environment pollutants in human milk, in many instances, they are at lower content than those found in cow’s milk or other foods. (Codex alimentarius FAO-WHO).
CAS Number: 7439-92-1
It is an environmental contaminant. As a heavy metal it is found in excess in products like paintings, fuel and metal industry. Certain make-ups, infusion herbals, meat from chased animals and ceramic made pottery may increase the risk of exposure. It can be stored in soft tissues for one month and in bones for decades. Removing of lead from bones occurs during pregnancy and lactation leading to an increase in the serum many years after exposure. It can cause cardiovascular and respiratory toxicity. More intensively it affects infants and children it may cause neurologic damage. Maximal accepted levels by international agencies like WHO, CDC, EFSA – even though a 0 level is desirable – are: 10 mcg/L in water, 5 mcg/L in breast milk and an ingestion of 2.5 mcg/k/d for infants less of 6 months of age. Absorption through the lungs is 50% and through the gut is less than 10%. In blood of unexposed persons serum levels should not be higher than 10 mcg/dL. Working mothers at fertile age showing a lead serum level higher than 30 mcg/dL should be removed from work place. Working pregnant or nursing women should be removed from places with high risk of toxin exposition (Regulated by EU Council Law/85/ from 19.10.1992). Mothers should not breastfeed if they are found to be intoxicated or contaminated. Same recommendation is suitable for mothers who undergo a chelating treatment (since lead is removed from bones and let free). Blood and breast milk testing is highly recommended to have lead level measured. Mothers should avoid nursing whenever lead level is higher than 16 mcg/L in the milk or 16 mcg/dL in the serum. (Lead levels in the milk are usually 10% of those in the serum). Benefits of breastfeeding widely overcome those issues related to the presence of low level environmental contaminants in human milk that in many instances are lower than those present in cow’s milk based products and other food. (Codex alimentarius FAO-WHO). Published papers from studies done on this matter have shown higher lead levels contained in powdered artificial milks than in human milk.
CAS Number: 7782-49-2
Essential trace element necessary for the functioning of the glutathione-peroxidase enzyme system that protects cellular structures from oxidative damage. It is obtained from foods such as vegetables, cereals, legumes, garlic, fish, seafood, eggs and meat. The amount of selenium in these sources depends on the concentration of selenium in the soil. The brazil nut (Bertholletia excelsa) is the food with the highest known concentrations of selenium. Selenium deficiency is very rare. With a staple diet it is not necessary to take selenium supplements in the absence of disease or a condition that may warrant it: parenteral nutrition, Crohn's disease, prematurity (MedlinePlus 2017). Taking too much selenium can cause selenosis, a condition that causes dermatological symptoms (alopecia, nail dystrophy), digestive symptoms, neurological symptoms and fatigue (MedlinePlus 2017).Nutritional supplements containing excessive amounts of selenium have resulted in severe poisoning (Aldosary 2012, Senthilkumaran 2012).The potential effects of selenium on cancer prevention, cardiovascular disease, and heavy metal poisoning and toxins are not proven, so supplementation of selenium other than from normal diet is not recommended (MedlinePlus 2017). The daily needs of selenium for breastfeeding mothers are 70-75 micrograms (mcg) daily. In infants it is 2 to 3 mcg/kg (10 mcg/day during the first 4 months) with a maximum of 30 mcg/day (MedlinePlus 2017, Kipp 2015). Selenium is found naturally in milk in its organic form of selenomethionine (Dorea 2002). The amount of selenium in colostrum is 80 mcg per litre and in mature milk 12-20 mcg/L, with no or very weak correlation with plasma selenium levels or daily intake of selenium (Wasowicz 2001, Bianchi 1999, Artaud 1993, Cummings 1992, Levander 1987, Higashi 1983). However, there are authors who find that selenium supplements for breastfeeding mothers increase selenium levels in milk and infants may exceed their daily needs for selenium. (Dorea 2002, Trafikowska 1996). Better plasma levels of selenium have been found in breastfed infants than in formula-fed infants (Strambi 2004, Sorvacheva 1996). There are lower plasma levels of selenium in babies born small for their gestational age (Strambi 2004).
CAS Number: 15064-65-0
The infant may receive radioactive emissions just by being held on mother’s lap. Pump-out mother’s milk some days before procedure is done and keep it frozen. After this, keep-on breast pumping (to stimulate milk production) and dispose extracted milk for the next two weeks. Use previously expressed milk to feed the infant, or/and infant formula, as necessary. Choose the shortest half-life span radionucleotide drug as possible.
Zinc (Zn) is an essential element for nutrition. It is present in many foods.Recommended daily allowance of Zn is 8 to 15 mg. (Moran Hall 2010). Millions of people worldwide are Zn-deficient.It is used as a treatment for Wilson's disease and Acrodermatitis Enteropathica. Zn is involved in the regulation process of lactation (Lee 2016).Pasteurization of the milk does not affect the concentration of Zn and other trace elements (Mohd Taufek-2016). The average concentration of Zn in breastmilk is 4 to 16 mg / L (Picciano 1976, Hannan 2005, Dórea 2012) which is independent of plasma levels and maternal daily intake (Krebs 1995, Chierici 1999, Hannan 2009).Intestinal absorption of zinc is almost doubled during pregnancy and lactation (Fung 1997).Zinc levels in the infant are dependent on Zinc levels in the breast milk (Dumrongwongsiri 2015)With a varied and balanced diet, an extra intake of minerals is not needed. Excessive intake of Zinc may cause gastrointestinal problems and Pancytopenia (Irving 2003).
CAS Number: 8015-60-9
Alfalfa (Medicago sativa) leaves and sprouts contain saponins, estrogenic isoflavinoids (e.g., dianzein genistein), vitamin K, and the amino acid L-canavanine. Alfalfa is a purported galactogogue and is included in some proprietary mixtures promoted to increase milk supply; however, no scientifically valid clinical trials support this use. Galactogogues should never replace evaluation and counseling on modifiable factors that affect milk production. Dianzein and genistein are excreted into breastmilk in small amounts, but have not been measured specifically after alfalfa intake. No data exist on the excretion of other components of alfalfa into breastmilk or on the safety and efficacy of alfalfa in nursing mothers or infants. Alfalfa is generally well tolerated and is "generally recognized as safe" (GRAS) as a food by the U.S. Food and Drug Administration. Worsening of systemic lupus erythematosus has been reported, possibly caused by immune system stimulation by L-canavanine. Because of its vitamin K content, alfalfa should be avoided in persons taking warfarin. Dietary supplements do not require extensive pre-marketing approval from the U.S. Food and Drug Administration. Manufacturers are responsible to ensure the safety, but do not need to the safety and effectiveness of dietary supplements before they are marketed. Dietary supplements may contain multiple ingredients, and differences are often found between labeled and actual ingredients or their amounts. A manufacturer may contract with an independent organization to verify the quality of a product or its ingredients, but that does certify the safety or effectiveness of a product. Because of the above issues, clinical testing results on one product may not be applicable to other products. More detailed information #about dietary supplements# is available elsewhere on the LactMed Web site.
CAS Number: 84696-05-9
Comfrey (Symphytum officinalis) herb and leaf contains allantoin and rosmarinic acid; comfrey also contains pyrrolizidine alkaloids. Comfrey preparations have been used topically for pain following episiotomy and cracked, painful nipples, either as aqueous preparations or in creams and ointments. Scientific evidence of effectiveness for these indications is minimal. The pyrrolizidine alkaloids in comfrey can cause severe liver damage, liver cancer, mutagenicity, and even death. For this reason, the U.S. Food and Drug Administration has banned the sale of oral comfrey products in the United States. Furthermore, most sources consider topical use of comfrey during breastfeeding to be contraindicated. If it is used on the skin, it should only be applied to intact skin away from the breast on the smallest area of skin possible, and for a limited duration. It is particularly important to ensure that the infant not come into direct contact with the areas of skin that have been treated, because ingestion may cause severe liver damage. Dietary supplements do not require extensive pre-marketing approval from the U.S. Food and Drug Administration. Manufacturers are responsible to ensure the safety, but do not need to the safety and effectiveness of dietary supplements before they are marketed. Dietary supplements may contain multiple ingredients, and differences are often found between labeled and actual ingredients or their amounts. A manufacturer may contract with an independent organization to verify the quality of a product or its ingredients, but that does certify the safety or effectiveness of a product. Because of the above issues, clinical testing results on one product may not be applicable to other products. More detailed information #about dietary supplements# is available elsewhere on the LactMed Web site.
CAS Number: 1339-63-5
Coenzyme Q10 (ubiquinone) is a normal part of the diet, and is also endogenously synthesized. It is a normal component of human milk, but milk levels are slightly low in the breastmilk of mothers with preterm infants. Coenzyme Q10 has no specific lactation-related uses and no data exist on the safety and efficacy of supplementation in nursing mothers or infants. Coenzyme Q10 supplements are usually well tolerated with only infrequent, minor side effects. Dietary supplements do not require extensive pre-marketing approval from the U.S. Food and Drug Administration. Manufacturers are responsible to ensure the safety, but do not need to the safety and effectiveness of dietary supplements before they are marketed. Dietary supplements may contain multiple ingredients, and differences are often found between labeled and actual ingredients or their amounts. A manufacturer may contract with an independent organization to verify the quality of a product or its ingredients, but that does certify the safety or effectiveness of a product. Because of the above issues, clinical testing results on one product may not be applicable to other products. More detailed information #about dietary supplements# is available elsewhere on the LactMed Web site.
CAS Number: 1327-53-3
Most sources consider breastfeeding to be contraindicated during maternal antineoplastic drug therapy. It might be possible to breastfeed safely during intermittent therapy with an appropriate period of breastfeeding abstinence; the manufacturer recommends an abstinence period of 1 week after the last dose. Chemotherapy may adversely affect the normal microbiome and chemical makeup of breastmilk. Women who receive chemotherapy during pregnancy are more likely to have difficulty nursing their infant.
CAS Number: 7727-43-7
Because barium sulfate is not absorbed after oral or rectal administration, it will not enter the milk, reach the bloodstream of the infant or cause any adverse effects in breastfed infants. No special precautions are required.
CAS Number: 554-13-2
Although lithium appears on many lists of drugs contraindicated during breastfeeding, other sources do not consider it an absolute contraindication, especially in infants over 2 months of age and during lithium monotherapy. Numerous reports exist of infants who were breastfed during maternal lithium therapy without any signs of toxicity or developmental problems. Most were breastfed from birth and some continued to nurse for up to 1 year of maternal lithium therapy. Limited data suggest that lithium in milk can adversely affect the infant when its elimination is impaired, as in dehydration or in newborn or premature infants. Neonates may also have transplacentally acquired serum lithium levels. Because maternal lithium requirements and dosage may be increased during pregnancy, maternal serum levels should be monitored frequently postpartum and dosage reduced as necessary to avoid excessive infant exposure via breastmilk. The long-term effects of lithium on infants are not certain, but limited data indicate no obvious problems in growth and development. Lithium may be used in mothers of fullterm infants who are willing and able to monitor their infants. Discontinuing lithium 24 to 48 hours before Cesarean section delivery or at the onset of spontaneous labor and resuming the prepregnancy lithium dose immediately after delivery should minimize the infant's serum lithium concentration at birth. Some investigators recommend monitoring infant serum lithium, serum creatinine, BUN, and TSH in intervals ranging from "periodic" to every 4 to 12 weeks during breastfeeding and maternal lithium therapy. However, others recommend close pediatric follow-up of the infant and only selective laboratory monitoring as clinically indicated. Breastfeeding should be discontinued immediately and the infant evaluated if the infant appears restless or lethargic or has feeding problems.
CAS Number: 3344-18-1
No information is available on the clinical use of magnesium citrate during breastfeeding. However, other magnesium salts have been studied. Intravenous magnesium sulfate increases milk magnesium concentrations only slightly. Oral absorption of magnesium by the infant is poor, so maternal magnesium citrate is not expected to affect the breastfed infant's serum magnesium. Magnesium citrate supplementation during pregnancy might delay the onset of lactation, but it can be taken during breastfeeding and no special precautions are required.
In most cases, it is okay to take mineral supplements like iron, calcium and copper. These have not been known to affect breast milk levels. However, taking large amounts of a dietary supplement while breast-feeding may be harmful to the mother and/or baby and should be avoided.
Due to high dilution of ingredients in homeopathic medicines they do not create much problem for baby. Free Radical is a homeopathic medicine and if your baby does not have any abnormal symptoms then there is nothing to worry about. Be careful with too much usage of ethanol based homeopathic medicines during breastfeeding.
Homeopathic medicines are usually safe in breastfeeding and if Free Radical has been recommended by doctor then there should be no concern about its usage in breastfeeding.
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week